Lunch & Posters 2 — ASN Events

Lunch & Posters 2 — ASN Events

Lunch & Posters 2

#PancreasSummit2025

Targeting Copper in combination with standard-of-care chemotherapy reduces fibrosis and metastasis in PDAC (#27)

Validating CXCL12/CXCR4 Axis as a Novel Target for Pain in Pancreatic Cancer (#28)

EUS-Guided Pancreatic Duct Drainage for Obstructive Pancreatitis Associated with Pancreatic Cancer: Report of Two Cases (#29)

Enhancing Biliary Tract Cancer Diagnosis Using AI-Driven 3D Optical Diffraction Tomography (#30)

Dong Hee DHK Koh

Central Pancreatectomy Combined with Sub-adventitial Divestment and Triangle Operation for Early-stage Pancreatic Neck Ductal Adenocarcinoma, A Case Report with Surgical Video Presentation (#31)

Sarcopenia and frailty as prognostic indicators in patients undergoing resection for pancreatic adenocarcinoma (#32)

Clinical Significance of Increased Skeletal Muscle Mass during Nab-paclitaxel Plus Gemcitabine Treatment in Patients with Advanced Pancreatic Cancer (#33)

Total Superior Mesenteric Artery Nerve Plexus Preservation During Pancreaticoduodenectomy for Pancreatic Cancer (#34)

Yoshihiro Miyazaki

Short-Term Outcomes of A Novel Posterior Approach for Retrograde Spleen and Splenic Vessels Preserving Distal Pancreatectomy: a Single Center Experience (#35)

Associations of Intra-pancreatic Fat Deposition with Incident Pancreatic Neoplasms Differ According to Carcinoma Types: A Study in Non-obese Individuals With Intraductal Papillary Mucinous Neoplasms (#36)

Beyond case reports: defining prognosis, biomarkers, and genomic patterns in pancreatic acinar cell carcinoma (#37)

Burden of Pancreatic Cancer Mortality in Australia: Epidemiological Trends and Clinical Implications (#38)

Immunological outcomes after distal pancreatectomy (#40)

The Significance of pancreaticoduodenectomy for Pancreatic Cancer in Patients Aged Over 80 in the era of multidisciplinary treatment: A Single-Center Retrospective Analysis (#41)

Simple prognostic markers for optimal treatment of patients with unresectable pancreatic cancer (#42)

ABO blood type and the long-term outcomes of pancreatic cancer (#43)

MZB1 Deficiency Enhances Macrophage and Neutrophil Chemotaxis to Accelerate Acute Pancreatitis Progression (#44)

ER stress-mediated PSC-macrophage interactions accelerate the progression of chronic alcoholic pancreatitis. (#45)

Single-cell transcriptomic atlas of peripheral blood reveals B cell-driven signature predictive of acute pancreatitis severity (#46)

Foreseeing Necrosectomy: clinical predictors of direct endoscopic debridement following endoscopic cysto-gastrostomy in pancreatic walled-off necrosis (#47)

Pleuropancreatic Fistula Resolution Despite Unseen Duct Disruption: A Case for Pancreatic Stenting (#48)

Tracking the ENCapsulation of pancreatic collections in acute necrotizing pancreatitis: Preliminary results of a serial MRI-based prospective study (MRI-ENCAP study) (#49)

Predicting Infected Pancreatic Necrosis in Acute Necrotizing Pancreatitis Using CT-based Radiomics: A Machine Learning Approach (#50)

Pancreatic pseudocysts in chronic pancreatitis: when should we intervene? (#51)

Stephanie M Macfarlane

High readmission following Complicated Acute Necrotizing Pancreatitis( RECAP Cohort) mandates close follow-up of patients (#52)

Evaluating reliability of structured computed tomography scan reporting in pancreatic cancer staging: Insights from a quality assurance study exploring inter- and intra-observer agreement and variability. (#7)